Trending Content - Investment Banking Forum
| +186 | UBS Accused of Favoring H-1B Workers While Cutting U.S.-Born Employees | 45 | 3h |
| +81 | IB Energy Drink Tier List / Ranking | 57 | 6m |
| +76 | PJT M&A Group Selection 2026 | 13 | 11h |
| +49 | ONLY THESE BANKS OR YOU STRUCK OUT | 13 | 23m |
| +36 | Quick Thoughts on CVC AI Sale Process | 7 | 3d |
| +33 | Feedback for internship first desk at IBD BB - personal fit, "don't be too confident" | 23 | 1d |
| +28 | Does BofA still pay its associates rat pellets? | 14 | 1h |
| +18 | What happened to Greenhill | 8 | 3d |
| +18 | Updated JPM Group Rankings | 30 | 2h |
| +18 | VP Deal Origination Credit | 2 | 10h |
Career Resources
Restructuring - you would get direct experience in OOC and Ch 11 bankruptcies
bump. Is the transition easy/possible from a low-tier RX IB (JEF/Baird/Piper)?
Don't have a direct answer to your question, but for context, even coming from an RX consulting background, you'll most likely get looks from distressed shops, especially in this market.
Do you have any stats behind that? I’m an AN1 RX consultant at A&M and haven’t seen any real exits (saw one post MBA associate go to a BB as an assoc1) but no distressed exits. Seems like all buy side opportunities want IB if not RX IB. Happy to hear a counter argument. Currently weighing A&M RX or one of the low tier RX IBs mentioned above for reference and looking to do distressed buy side in the future.
Cumque eligendi aut enim libero veritatis et. Vero est qui a eum necessitatibus ea reiciendis. Veritatis sed nisi nam nemo dolorem numquam voluptatibus ratione. Corrupti qui dolorem animi velit est. Maxime velit quia quae nemo iure sapiente.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...